As the CF treatment landscape continues to evolve, consolidating the knowledge of the synthetic routes and MoA of CFTR modulators may provide valuable insights for the development of alternate, more efficacious, and/or cost-effective CF therapies, expanding the range of variants amenable to modulation. Here, CFTR is linked to cystic fibrosis.